El Rey Treatment Facility is categorized under Outpatient Services in Seattle, WA and active since 1988.
El Rey Treatment Facility was established in 1988, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Outpatient Services business, which does work in the B2C market, and is classified as a Outpatient Services, under code number 6222100 by the NAICS.
If you are seeking more information, feel free to contact Marty Ruybalid, Manager at the company’s single location by writing to 2119 2nd Avenue, Seattle, Washington WA 98121 or by phoning (206) 461-6923. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | El Rey Treatment Facility |
Contact Person: | Marty Ruybalid, Manager |
Address: | 2119 2nd Avenue, Seattle, Washington 98121 |
Phone Number: | (206) 461-6923 |
Website Address: | cpcwa.org |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 1988 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Outpatient Services |
SIC Code: | 8093 |
NAICS Code: | 6222100 |
Share This Business: |
El Rey Treatment Facility was started in 1988 to provide professional Outpatient Services under the SIC code 8093 and NAICS code 6222100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Marty Ruybalid, Manager for inquiries that concern El Rey Treatment Facility by calling the company number (206) 461-6923, as your correspondence is most welcome. Additionally, the physical location of the single location of El Rey Treatment Facility can be found at the coordinates 47.612833,-122.343744 as well as the street address 2119 2nd Avenue in Seattle, Washington 98121.
For its online presence, you may visit El Rey Treatment Facility’s website at cpcwa.org and engage with its social media outlets through on Twitter and on Facebook.